Nab Mitotax 100 mg Injection
$84.98
$66.56
Nab Mitotax 100 mg Injection is an effective microtubule inhibitor designed to treat metastatic breast cancer in patients who have experienced failure with prior combination chemotherapy or those who have relapsed within six months of receiving adjuvant chemotherapy. This medication can be administered alongside carboplatin as a primary treatment option for locally advanced or metastatic non-small cell lung cancer in individuals who are not candidates for radical surgical intervention or radiation therapy. Additionally, Nab Mitotax is utilized in combination with gemcitabine as an initial therapy for metastatic pancreatic cancer, enhancing treatment outcomes in challenging cases. It’s important for patients to be aware of potential side effects, including allergic reactions or blood-related issues, and to discuss these with their healthcare provider prior to treatment. Administered via injection, Nab Mitotax provides a vital therapeutic avenue for those battling aggressive cancers, helping to improve survival rates and quality of life. As with any chemotherapy agent, close monitoring during treatment is essential to manage any adverse effects effectively. By incorporating Nab Mitotax into a comprehensive treatment plan, healthcare professionals can offer renewed hope to patients facing advanced cancer stages. Always consult your oncologist to ensure this treatment aligns with your individual health needs and circumstances.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Nab mitotax 100 mg injection is utilized in the treatment of metastatic breast cancer, which occurs when breast cancer cells spread to other areas of the body, such as the bones, liver, lungs, or brain. This medication helps to target and eliminate cancer cells, thereby slowing the progression of the disease. Patients receiving Nab mitotax may experience an improvement in symptoms and overall quality of life. It is often used in conjunction with other therapies to enhance treatment efficacy.
• In the management of Non-Small Cell Lung Cancer (NSCLC), Nab mitotax 100 mg injection serves as an effective therapeutic option. NSCLC originates in the lung tissues and can metastasize to various organs, leading to symptoms like coughing and chest pain. By administering Nab mitotax, healthcare providers aim to reduce tumor size and improve respiratory function. This treatment is crucial for patients who require advanced care for this aggressive form of lung cancer.
• Nab mitotax 100 mg injection is also indicated for the treatment of ovarian cancer, a malignancy that begins in the ovaries. Often asymptomatic in its early stages, ovarian cancer can manifest with vague symptoms as it progresses. The use of Nab mitotax helps to target and destroy malignant cells, potentially improving survival rates and quality of life for affected individuals. This treatment is particularly important for patients diagnosed at later stages of the disease.
• For patients diagnosed with pancreatic adenocarcinoma, Nab mitotax 100 mg injection is a vital treatment option. This cancer type typically arises in the pancreas and may not present symptoms until it reaches an advanced stage. By utilizing Nab mitotax, oncologists aim to control tumor growth and alleviate symptoms such as abdominal pain and jaundice. This intervention is essential for managing the disease and enhancing patient outcomes during treatment.
Benefits
Nab Mitotax 100 mg Injection is an anticancer medicine that is used to treat many types of cancer, which include breast cancer, lung cancer, ovarian cancer, and pancreatic cancer.it's known to be efficient in treating different types of cancer either alone or in a mixture with other chemotherapy medications or radiation therapy. Nab Mitotax 100 mg interfering with the division of cancer cells, kills or stops the growth of cancer cells and prevents the multiplication of cancer cells and relieves the symptoms of breast cancer and stomach cancer. Anti-cancer Drug Nab Mitotax can improve overall survival and disease-free survival in patients with HER2-positive breast cancer when used in combination with other cancer treatments.
Side Effects
Like all medications, Nab Mitotax Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Hair loss
• Peripheral neuropathy
• Abnormal ECG
• Low blood count
• Nausea
• Vomiting
• Diarrhoea
• Loss of appetite
• Arthralgia ( joint pain)
• Myalgia (muscle pain)
• Mouth sores
• Headache
Common Side Effects
• Irregular Heartbeats ( Tachycardia/Bradycardia)
• Vision changes
• Bleeding
• Dizziness
• Vision changes
How To Use
Anti-cancer Drug Nab Mitotax is an intravenous infusion, administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of the Nab Mitotax 100 mg Injection will be determined by the patient's clinical condition, age, medical history, type of cancer and other factors. It is important to note that this Nab Mitotax 100 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Nab Mitotax 100 mg Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Nab Mitotax 100 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Nab Mitotax 100 mg Injection is safe to use in patients with kidney disease. No dose adjustment of Nab Mitotax 100 mg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Nab Mitotax 100 mg Injection. Nab Mitotax 100 mg Vial may pass into breast milk and harm the infant. If you are breastfeeding and taking Nab Mitotax 100 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Nab Mitotax 100 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Nab Mitotax 100 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Albumin Bound Paclitaxel Injection 100 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Nab Mitotax 100 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Nab Mitotax 100 mg Vial during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Nab Mitotax 100 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Albumin Bound Paclitaxel Injection 100 mg.